Tecan Group Ltd. header image

Tecan Group Ltd.

TECN

Equity

ISIN CH0012100191 / Valor 1210019

SIX Swiss Exchange (2026-08-05)
CHF 193.80%

Tecan Group Ltd.
UMushroom community rating:

star star star star star
3.75 2 votes No rating yet
NegativeNeutralPositive

About company

Tecan Group Ltd. is a Swiss company specializing in laboratory instruments and solutions for the life sciences and healthcare sectors. The company provides a range of products and services designed to enhance the precision, reproducibility, and compliance of laboratory processes and medical procedures. Tecan's offerings include automated laboratory instruments, software solutions, and comprehensive services that support customers from the initial stages of innovation through to project implementation and ongoing operations. By focusing on scalable and reliable outcomes, Tecan plays a crucial role in advancing research and development in various scientific fields, contributing to significant advancements in healthcare and life sciences.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

24.5%1Y
-42.1%3Y
-63.4%5Y

Performance

36.9%1Y
35.4%3Y
37.4%5Y

Volatility

Market cap

3012 M

Market cap (USD)

Daily traded volume (Shares)

23,037

Daily traded volume (Shares)

1 day high/low

206.6 / 203.4

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.75

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
2.25
Society:
starstarstarstarstar
2.25
Nature:
starstarstarstarstar
1.50
Anna Trillini
Switzerland, 15 Oct 2025
star star star star star
/
Patrik Schmocker
Switzerland, 24 Mar 2025
star star star star star
.

EQUITIES OF THE SAME SECTOR

Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.71%USD 6.28
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 0.96
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%USD 302.57
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.12%USD 67.06
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.63%USD 1.95
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.34%USD 22.84
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 16.00
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%GBP 15.71
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%EUR 41.15
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%EUR 12.60